Market Research Logo

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Mitsubishi Tanabe Pharma Corporation (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corporation, is a pharmaceutical company. The company identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes and kidney diseases, central nervous system (CNS) diseases and others, and it also develops vaccines. The company major products include remicade, simponi, tenelia, ceredist and lexapro. Mitsubishi Tanabe major products include flucort f, nanpao, alegysal bien and okinazole. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It also offers fine chemicals, information services, real-estate leasing and advertising, among others. The company along with its subsidiaries operates in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Mitsubishi Tanabe Pharma Corporation Key Recent Developments

Aug 02, 2016: Mitsubishi Tanabe Pharma Announces Financial Results for the First Three Months of the Fiscal year ending March 31, 2017
Jun 06, 2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com
Jun 06, 2016: Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund
Apr 01, 2016: MT Pharma Singapore Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore
Mar 29, 2016: Astellas and Mitsubishi Tanabe Pharma Execute Agreement for Share of Compound Libraries

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Mitsubishi Tanabe Pharma Corporation - Key Facts
Mitsubishi Tanabe Pharma Corporation - Key Employees
Mitsubishi Tanabe Pharma Corporation - Key Employee Biographies
Mitsubishi Tanabe Pharma Corporation - Major Products and Services
Mitsubishi Tanabe Pharma Corporation - Pharmaceutical Pipeline Products Data
Mitsubishi Tanabe Pharma Corporation, Pipeline Products by Therapy Area
Mitsubishi Tanabe Pharma Corporation, Pipeline Products by Development Phase
Mitsubishi Tanabe Pharma Corporation - History
Mitsubishi Tanabe Pharma Corporation - Company Statement
Mitsubishi Tanabe Pharma Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Mitsubishi Tanabe Pharma Corporation - Business Description
Mitsubishi Tanabe Pharma Corporation - Corporate Strategy
Mitsubishi Tanabe Pharma Corporation - SWOT Analysis
SWOT Analysis - Overview
Mitsubishi Tanabe Pharma Corporation - Strengths
Strength - Liquidity Position
Strength - Research and Development
Strength - Improved Performance of Pharmaceutical Segment
Mitsubishi Tanabe Pharma Corporation - Weaknesses
Weakness - Debt Burden
Mitsubishi Tanabe Pharma Corporation - Opportunities
Opportunity - Strategic Initiatives
Opportunity - Growing Market for Rheumatoid Arthritis
Opportunity - Promising Pipeline Products
Mitsubishi Tanabe Pharma Corporation - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Environment
Threat - Government Regulations
Mitsubishi Tanabe Pharma Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mitsubishi Tanabe Pharma Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 02, 2016: Mitsubishi Tanabe Pharma Announces Financial Results for the First Three Months of the Fiscal year ending March 31, 2017
Jun 06, 2016: Mitsubishi Tanabe Pharma contribute funding to Global Health Innovative Technology Fund
Jun 06, 2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com
Apr 01, 2016: MT Pharma Singapore Starts Business Operations Mitsubishi Tanabe Pharma’s Subsidiary in Singapore
Mar 29, 2016: Astellas and Mitsubishi Tanabe Pharma Execute Agreement for Share of Compound Libraries
Feb 23, 2016: Mitsubishi Tanabe Pharma Enhances Operations in the United States
Feb 03, 2016: Mitsubishi Tanabe Pharma Reports Net Sales Of JPY340.9 Billion For The Nine Months Ended December 31, 2015
Nov 30, 2015: Mitsubishi Tanabe Pharma Formulates Medium-Term Management Plan 16-20: Open Up the Future
Oct 30, 2015: Mitsubishi Tanabe Pharma Reports Net Sales Of JPY201.7 Billion For The Six Months Ended September 30, 2015
Jul 31, 2015: Mitsubishi Tanabe Pharma Reports Net Sales Of JPY98.5 Billion In Q1 Fiscal 2016
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Mitsubishi Tanabe Pharma Corporation, Key Facts
Mitsubishi Tanabe Pharma Corporation, Key Employees
Mitsubishi Tanabe Pharma Corporation, Key Employee Biographies
Mitsubishi Tanabe Pharma Corporation, Major Products and Services
Mitsubishi Tanabe Pharma Corporation, Number of Pipeline Products by Therapy Area
Mitsubishi Tanabe Pharma Corporation, Number of Pipeline Products by Development Stage
Mitsubishi Tanabe Pharma Corporation, Pipeline Products By Therapy Area and Development Phase
Mitsubishi Tanabe Pharma Corporation, History
Mitsubishi Tanabe Pharma Corporation, Other Locations
Mitsubishi Tanabe Pharma Corporation, Subsidiaries
Mitsubishi Tanabe Pharma Corporation, Key Competitors
Mitsubishi Tanabe Pharma Corporation, Ratios based on current share price
Mitsubishi Tanabe Pharma Corporation, Annual Ratios
Mitsubishi Tanabe Pharma Corporation, Interim Ratios
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Mitsubishi Tanabe Pharma Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Mitsubishi Tanabe Pharma Corporation, Pipeline Products by Therapy Area
Mitsubishi Tanabe Pharma Corporation, Pipeline Products by Development Phase
Mitsubishi Tanabe Pharma Corporation, Performance Chart (2012 - 2016)
Mitsubishi Tanabe Pharma Corporation, Ratio Charts
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Mitsubishi Tanabe Pharma Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report